Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
Year: 2002
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: C M Tam, S L Chan, K M Kam, R L Goodall, D A Mitchison
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2404331567
